| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
57,080,000 |
| Market
Cap: |
172.95(M) |
| Last
Volume: |
97,895 |
Avg
Vol: |
97,624 |
| 52
Week Range: |
$1.32 - $4.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 5.4 |
| Insider 6 Months : 6.1 |
| Insider 3/6 Months : 11.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,500 |
5,000 |
6,598 |
33,898 |
| Total Buy Value |
$14,360 |
$15,253 |
$18,107 |
$61,191 |
| Total People Bought |
3 |
4 |
4 |
5 |
| Total Buy Transactions |
3 |
4 |
5 |
12 |
| Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
| Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
| Total People Sold |
1 |
1 |
1 |
2 |
| Total Sell Transactions |
2 |
2 |
2 |
4 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Czirr James C |
Executive Chairman |
• • – |
2014-01-27 |
4 |
OE |
$3.00 |
$1,500,000 |
I/I |
500,000 |
2,776,186 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2014-01-27 |
4 |
OE |
$3.00 |
$1,332,498 |
D/D |
444,166 |
2,776,186 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
I/I |
(58,000) |
9,357,422 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
D/D |
(58,000) |
9,357,422 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2014-01-13 |
4 |
S |
$14.00 |
$812,203 |
I/I |
(58,000) |
9,357,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
I/I |
(42,000) |
9,415,422 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
D/D |
(42,000) |
9,415,422 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2014-01-10 |
4 |
S |
$16.00 |
$672,118 |
I/I |
(42,000) |
9,415,422 |
|
- |
|
| Shlevin Harold H. |
Chief Operating Officer |
• – – |
2014-01-10 |
4 |
D |
$13.49 |
$115,996 |
D/D |
(8,598) |
95,316 |
|
- |
|
| Shlevin Harold H. |
Chief Operating Officer |
• – – |
2014-01-10 |
4 |
OE |
$2.32 |
$116,000 |
D/D |
50,000 |
103,914 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2014-01-02 |
4 |
AB |
$8.01 |
$4,950 |
D/D |
618 |
18,074 |
|
- |
|
| Traber Peter G |
President and CEO |
• • – |
2013-12-09 |
4 |
B |
$8.90 |
$4,450 |
D/D |
500 |
96,333 |
2.73 |
- |
|
| Traber Peter G |
President and CEO |
• • – |
2013-12-05 |
4 |
B |
$9.00 |
$4,500 |
D/D |
500 |
95,833 |
2.73 |
- |
|
| Rubin Marc |
Director |
– • – |
2013-12-04 |
4 |
B |
$8.69 |
$26,070 |
D/D |
3,000 |
6,334 |
2.39 |
- |
|
| Mauldin John F |
Director |
– • – |
2013-12-02 |
4 |
AB |
$8.20 |
$4,992 |
D/D |
609 |
17,456 |
|
- |
|
| Callicutt Jack W |
Chief Financial Officer |
• – – |
2013-11-19 |
4 |
B |
$6.25 |
$1,625 |
D/D |
260 |
260 |
2.66 |
- |
|
| Greenberg Arthur |
Director |
– • – |
2013-11-19 |
4 |
B |
$6.55 |
$13,102 |
D/D |
2,000 |
95,667 |
2.39 |
- |
|
| Traber Peter G |
President and CEO |
• • – |
2013-11-19 |
4 |
B |
$5.53 |
$5,530 |
D/D |
1,000 |
95,333 |
2.81 |
- |
|
| Freeman Kevin D |
Director |
– • – |
2013-11-18 |
4 |
B |
$6.08 |
$6,078 |
D/D |
1,000 |
2,917 |
2.39 |
- |
|
| Traber Peter G |
President and CEO |
• • – |
2013-11-18 |
4 |
B |
$5.80 |
$5,799 |
D/D |
1,000 |
511,000 |
2.81 |
- |
|
| Shlevin Harold H. |
Chief Operating Officer |
• – – |
2013-11-18 |
4 |
B |
$6.63 |
$3,315 |
D/D |
500 |
53,914 |
2.66 |
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-11-15 |
4 |
B |
$6.90 |
$6,897 |
D/D |
1,000 |
844,450 |
2.81 |
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2013-11-01 |
4 |
OE |
$3.00 |
$600,000 |
D/D |
200,000 |
9,457,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-11-01 |
4 |
OE |
$3.00 |
$150,000 |
D/D |
50,000 |
9,457,422 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2013-11-01 |
4 |
OE |
$3.00 |
$450,000 |
I/I |
150,000 |
9,407,422 |
|
- |
|
517 Records found
|
|
Page 14 of 21 |
|
|
0.22 (6.77%) 
